<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00593229</url>
  </required_header>
  <id_info>
    <org_study_id>DK71221</org_study_id>
    <secondary_id>DK R21-71221</secondary_id>
    <nct_id>NCT00593229</nct_id>
  </id_info>
  <brief_title>International Registry and Biorepository for TMA(Thrombotic Microangiopathy)</brief_title>
  <official_title>An Observational Study of All Forms of Thrombotic Microangiopathy in Pediatric Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwell Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Children's Hospital of Philadelphia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mario Negri Institute for Pharmacological Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Montreal Children's Hospital of the MUHC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stollery Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Northwell Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This registry will collect clinical data and store biosamples (seru, plasma, urine, and DNA)
      annually from pediatric patients with thrombotic mcroangiopathy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Children age, 6 months - 18 years, are eligible if they have one of the following categories
      of thrombotic microangiopathy (TMA):(1) severe D+HUS; (2) non-familial atypical HUS; (3)
      familial atypical HUS; or (4) TTP

      Patients are seen intially and annually thereafter

      Biosamples are collected for storage annually.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    study stopped at this site, as investigator left the institution
  </why_stopped>
  <start_date>January 2007</start_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Determine epidemiology and outcomes of the various forms of TMA</measure>
    <time_frame>Ongoing</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Determine genetic causes of TMA</measure>
    <time_frame>Ongoing</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Initiate clinical trials in TMA</measure>
    <time_frame>In the future</time_frame>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">6</enrollment>
  <condition>Thrombotic Microangiopathy</condition>
  <condition>Hemolytic Uremic Syndrome</condition>
  <condition>Thrombotic Thrombocytopenic Purpura</condition>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>Familial atypical HUS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <description>Thrombotic thrombocytopenic purpura (TTP)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Severe diarrhea-associated hemolytic uremic syndrome (D+HUS)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Non-familial atypical HUS</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, plasma, urine, and DNA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pediatric patients, 6 months - 18 years
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Severe HUS, familial or non-familial atypical HUS, TTP

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Howard Trachtman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Schneider Children's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Schneider Chldren's Hospital</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 2, 2008</study_first_submitted>
  <study_first_submitted_qc>January 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2008</study_first_posted>
  <last_update_submitted>June 18, 2013</last_update_submitted>
  <last_update_submitted_qc>June 18, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 19, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Thrombotic microangiopathy (TMA)</keyword>
  <keyword>Hemolytic uremic syndrome (HUS)</keyword>
  <keyword>Thrombotic thrombocytopenic purpura (TTP)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Purpura</mesh_term>
    <mesh_term>Purpura, Thrombocytopenic</mesh_term>
    <mesh_term>Hemolysis</mesh_term>
    <mesh_term>Hemolytic-Uremic Syndrome</mesh_term>
    <mesh_term>Purpura, Thrombotic Thrombocytopenic</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Thrombotic Microangiopathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

